Screening of reactivation potency was performed with two concentrations of reactivator using rat brain homogenate as the source of AChE. Results were compared with established reactivators pralidoxime, methoxime, HI-6, trimedoxime and obidoxime.
More than 30 novel reactivators performed equal or better reactivation ability of POX-inhibited AChE compared to currently used reactivators. SAR were developed.